(Q38959470)

8 September 2017

title

Myricetin exerts anti-proliferative, anti-invasive, and pro-apoptotic effects on esophageal carcinoma EC9706 and KYSE30 cells via RSK2. (English)

1 reference

8 September 2017

0 references

1 reference

Wenqiao Zang

1

1 reference

8 September 2017

Tao Wang

2

1 reference

8 September 2017

Yuanyuan Wang

3

1 reference

8 September 2017

Min Li

4

1 reference

8 September 2017

Xiaoyan Xuan

5

1 reference

8 September 2017

Yunyun Ma

6

1 reference

8 September 2017

Yuwen Du

7

1 reference

8 September 2017

Kangdong Liu

8

1 reference

8 September 2017

Ziming Dong

9

1 reference

8 September 2017

Guoqiang Zhao

10

1 reference

8 September 2017

language of work or name

1 reference

6 September 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

35

1 reference

8 September 2017

issue

12

1 reference

8 September 2017

page(s)

12583-12592

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-014-2579-4

8 September 2017

exact match

0 references

cites work

ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

A Xenopus ribosomal protein S6 kinase has two apparent kinase domains that are each similar to distinct protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

The p90 ribosomal S6 kinase (RSK) is a mediator of smooth muscle contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

The ERK cascade: a prototype of MAPK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Physiological roles of ribosomal protein S6: one of its kind

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Potential anticancer activity of myricetin in human T24 bladder cancer cells both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Myricetin suppresses UVB-induced skin cancer by targeting Fyn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

The RSK family of kinases: emerging roles in cellular signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

RSK2 protein suppresses integrin activation and fibronectin matrix assembly and promotes cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

RSK in tumorigenesis: connections to steroid signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

SHAFTS: a hybrid approach for 3D molecular similarity calculation. 2. Prospective case study in the discovery of diverse p90 ribosomal S6 protein kinase 2 inhibitors to suppress cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Tumor necrosis factor receptor-associated factor family protein 2 is a key mediator of the epidermal growth factor-induced ribosomal S6 kinase 2/cAMP-responsive element-binding protein/Fos protein signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Structural Diversity of the Active N-Terminal Kinase Domain of p90 Ribosomal S6 Kinase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

RSK2(Ser227) at N-terminal kinase domain is a potential therapeutic target for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

RSK2 is a kinetochore-associated protein that participates in the spindle assembly checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Phosphorylation of the pro-apoptotic protein BAD on serine 155, a novel site, contributes to cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2579-4

Perspectives: signal transduction. Cell survival demands some Rsk

21 January 2018

1 reference

12 December 2020

Role of p90(RSK) in regulating the Crabtree effect: implications for cancer

1 reference

12 December 2020

The Mad side of the Max network: antagonizing the function of Myc and more.

1 reference

12 December 2020

Effect of myricetin on 1,2 dimethylhydrazine induced rat colon carcinogenesis

1 reference

12 December 2020

10.1007/S13277-014-2579-4

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1009579292

0 references

1 reference